AST 0 3 0 3 B-clinical_variable
and 4 7 4 7 I-clinical_variable
ALT 8 11 8 11 I-clinical_variable
are 12 15 12 15 O
each 16 20 16 20 O
≤5 21 23 21 23 O
× 24 25 24 25 I-upper_bound
the 26 29 26 29 I-upper_bound
ULN 30 33 30 33 I-upper_bound

Absolute 0 8 34 42 B-clinical_variable
neutrophil 9 19 43 53 I-clinical_variable
count 20 25 54 59 I-clinical_variable
( 26 27 60 61 I-clinical_variable
ANC 27 30 61 64 I-clinical_variable
) 30 31 64 65 I-clinical_variable
≥1,500 32 38 66 72 O
/ 38 39 72 73 I-lower_bound
mm3 39 42 73 76 I-lower_bound

Active 0 6 77 83 B-chronic_disease
bacterial 7 16 84 93 I-chronic_disease
, 16 17 93 94 O
viral 18 23 95 100 B-chronic_disease
, 23 24 100 101 O
or 25 27 102 104 O
fungal 28 34 105 111 B-chronic_disease
infection 35 44 112 121 I-chronic_disease
requiring 45 54 122 131 O
systemic 55 63 132 140 B-treatment
therapy 64 71 141 148 I-treatment

Alanine 0 7 149 156 B-clinical_variable
aminotransferase 8 24 157 173 I-clinical_variable
( 25 26 174 175 I-clinical_variable
ALT 26 29 175 178 I-clinical_variable
[ 30 31 179 180 I-clinical_variable
SGPT 31 35 180 184 I-clinical_variable
] 35 36 184 185 I-clinical_variable
) 36 37 185 186 I-clinical_variable
≤2.5 38 42 187 191 O
× 43 44 192 193 I-upper_bound
the 45 48 194 197 I-upper_bound
ULN 49 52 198 201 I-upper_bound

Any 0 3 202 205 O
cytotoxic 4 13 206 215 B-treatment
chemotherapy 14 26 216 228 I-treatment
within 27 33 229 235 O
21 34 36 236 238 B-upper_bound
days 37 41 239 243 I-upper_bound
prior 42 47 244 249 I-upper_bound
to 48 50 250 252 O
initiation 51 61 253 263 O
of 62 64 264 266 O
study 65 70 267 272 B-treatment
drug 71 75 273 277 I-treatment

Any 0 3 278 281 O
immunomodulatory 4 20 282 298 B-treatment
drug 21 25 299 303 I-treatment
therapy 26 33 304 311 I-treatment
, 33 34 311 312 O
anti 35 39 313 317 B-treatment
- 39 40 317 318 I-treatment
neoplastic 40 50 318 328 I-treatment
hormonal 51 59 329 337 I-treatment
therapy 60 67 338 345 I-treatment
( 68 69 346 347 O
unless 69 75 347 353 O
dose 76 80 354 358 O
has 81 84 359 362 O
been 85 89 363 367 O
stable 90 96 368 374 O
for 97 100 375 378 O
3 101 102 379 380 B-upper_bound
months 103 109 381 387 I-upper_bound
prior 110 115 388 393 I-upper_bound
to 116 118 394 396 O
Baseline 119 127 397 405 O
and 128 131 406 409 O
will 132 136 410 414 O
remain 137 143 415 421 O
stable 144 150 422 428 O
during 151 157 429 435 O
the 158 161 436 439 O
trial 162 167 440 445 O
) 167 168 445 446 O

Aspartate 0 9 447 456 B-clinical_variable
aminotransferase 10 26 457 473 I-clinical_variable
( 27 28 474 475 I-clinical_variable
AST 28 31 475 478 I-clinical_variable
[ 32 33 479 480 I-clinical_variable
SGOT 33 37 480 484 I-clinical_variable
] 37 38 484 485 I-clinical_variable
) 38 39 485 486 I-clinical_variable
≤2.5 40 44 487 491 O
× 45 46 492 493 I-upper_bound
the 47 50 494 497 I-upper_bound
ULN 51 54 498 501 I-upper_bound

Clinically 0 10 502 512 O
significant 11 22 513 524 O
hearing 23 30 525 532 B-chronic_disease
impairment 31 41 533 543 I-chronic_disease
, 41 42 543 544 O
as 43 45 545 547 O
judged 46 52 548 554 O
by 53 55 555 557 O
the 56 59 558 561 O
Principal 60 69 562 571 O
Investigator 70 82 572 584 O

Eastern 0 7 585 592 B-clinical_variable
Collaborative 8 21 593 606 I-clinical_variable
Oncology 22 30 607 615 I-clinical_variable
Group 31 36 616 621 I-clinical_variable
( 37 38 622 623 I-clinical_variable
ECOG 38 42 623 627 I-clinical_variable
) 42 43 627 628 I-clinical_variable
Performance 44 55 629 640 I-clinical_variable
Status 56 62 641 647 I-clinical_variable
of 63 65 648 650 O
0 66 67 651 652 B-lower_bound
- 67 68 652 653 O
1 68 69 653 654 B-upper_bound
( 70 71 655 656 O
Appendix 71 79 656 664 O
1 80 81 665 666 O
) 81 82 666 667 O

Evaluable 0 9 668 677 O
disease 10 17 678 685 O
, 17 18 685 686 O
either 19 25 687 693 O
measurable 26 36 694 704 O
on 37 39 705 707 O
physical 40 48 708 716 B-treatment
examination 49 60 717 728 I-treatment

Known 0 5 729 734 O
human 6 11 735 740 B-chronic_disease
immunodeficiency 12 28 741 757 I-chronic_disease
virus 29 34 758 763 I-chronic_disease
or 35 37 764 766 O
acquired 38 46 767 775 B-chronic_disease
immunodeficiency 47 63 776 792 I-chronic_disease
syndrome 64 72 793 801 I-chronic_disease
related 73 80 802 809 O
illness 81 88 810 817 O

Life 0 4 818 822 B-clinical_variable
expectancy 5 15 823 833 I-clinical_variable
< 16 17 834 835 O
12 17 19 835 837 B-upper_bound
weeks 20 25 838 843 I-upper_bound

Major 0 5 844 849 B-treatment
surgery 6 13 850 857 I-treatment
within 14 20 858 864 O
28 21 23 865 867 B-upper_bound
days 24 28 868 872 I-upper_bound
prior 29 34 873 878 I-upper_bound
to 35 37 879 881 O
initiation 38 48 882 892 O
of 49 51 893 895 O
study 52 57 896 901 B-treatment
drug 58 62 902 906 I-treatment

Negative 0 8 907 915 O
serum 9 14 916 921 O
β 15 16 922 923 O
hCG 17 20 924 927 O
( 21 22 928 929 O
human 22 27 929 934 O
chorionic 28 37 935 944 O
gonadotropin 38 50 945 957 O
) 50 51 957 958 O
test 52 56 959 963 O
in 57 59 964 966 O
women 60 65 967 972 B-gender
of 66 68 973 975 O
childbearing 69 81 976 988 O
potential 82 91 989 998 O
( 92 93 999 1000 O
defined 93 100 1000 1007 O
as 101 103 1008 1010 O
women 104 109 1011 1016 O
≤50 110 113 1017 1020 O
years 114 119 1021 1026 O
of 120 122 1027 1029 O
age 123 126 1030 1033 B-age
, 126 127 1033 1034 O
or 128 130 1035 1037 O
> 131 132 1038 1039 O
50 132 134 1039 1041 O
years 135 140 1042 1047 O
of 141 143 1048 1050 O
age 144 147 1051 1054 O
with 148 152 1055 1059 O
a 153 154 1060 1061 O
history 155 162 1062 1069 O
of 163 165 1070 1072 O
amenorrhea 166 176 1073 1083 B-chronic_disease
for 177 180 1084 1087 O
≤12 181 184 1088 1091 O
months 185 191 1092 1098 I-upper_bound
prior 192 197 1099 1104 I-upper_bound
to 198 200 1105 1107 O
study 201 206 1108 1113 O
entry 207 212 1114 1119 O
) 212 213 1119 1120 O

Pathologically 0 14 1121 1135 O
confirmed 15 24 1136 1145 O
advanced 25 33 1146 1154 O
solid 34 39 1155 1160 B-cancer
tumor 40 45 1161 1166 I-cancer
for 46 49 1167 1170 O
which 50 55 1171 1176 O
standard 56 64 1177 1185 B-treatment
therapy 65 72 1186 1193 I-treatment
proven 73 79 1194 1200 O
to 80 82 1201 1203 O
provide 83 90 1204 1211 O
clinical 91 99 1212 1220 O
benefit 100 107 1221 1228 O
does 108 112 1229 1233 O
not 113 116 1234 1237 O
exist 117 122 1238 1243 O
or 123 125 1244 1246 O
is 126 128 1247 1249 O
no 129 131 1250 1252 O
longer 132 138 1253 1259 O
effective 139 148 1260 1269 O

Platelets 0 9 1270 1279 B-clinical_variable
≥100,000 10 18 1280 1288 O
/ 18 19 1288 1289 I-lower_bound
mm3 19 22 1289 1292 I-lower_bound

Presence 0 8 1293 1301 O
of 9 11 1302 1304 O
an 12 14 1305 1307 O
acute 15 20 1308 1313 O
or 21 23 1314 1316 O
chronic 24 31 1317 1324 O
toxicity 32 40 1325 1333 O
of 41 43 1334 1336 O
prior 44 49 1337 1342 B-treatment
chemotherapy 50 62 1343 1355 I-treatment
, 62 63 1355 1356 O
with 64 68 1357 1361 O
the 69 72 1362 1365 O
exception 73 82 1366 1375 O
of 83 85 1376 1378 O
alopecia 86 94 1379 1387 B-chronic_disease
, 94 95 1387 1388 O
that 96 100 1389 1393 O
has 101 104 1394 1397 O
not 105 108 1398 1401 O
resolved 109 117 1402 1410 O
to 118 120 1411 1413 O
≤Grade 121 127 1414 1420 O
1 128 129 1421 1422 I-upper_bound
, 129 130 1422 1423 O
as 131 133 1424 1426 O
determined 134 144 1427 1437 O
by 145 147 1438 1440 O
National 148 156 1441 1449 O
Cancer 157 163 1450 1456 O
Institute 164 173 1457 1466 O
Common 174 180 1467 1473 O
Toxicity 181 189 1474 1482 O
Criteria 190 198 1483 1491 O
for 199 202 1492 1495 O
Adverse 203 210 1496 1503 O
Effects 211 218 1504 1511 O
( 219 220 1512 1513 O
CTCAE 220 225 1513 1518 O
) 225 226 1518 1519 O
v 227 228 1520 1521 O
4.0 229 232 1522 1525 O
( 233 234 1526 1527 O
http://evs.nci.nih.gov/ftp1/CTCAE/About.html 234 278 1527 1571 O
) 278 279 1571 1572 O

Previous 0 8 1573 1581 O
malignancy 9 19 1582 1592 B-chronic_disease

Radiotherapy 0 12 1593 1605 B-treatment
within 13 19 1606 1612 O
28 20 22 1613 1615 B-upper_bound
days 23 27 1616 1620 I-upper_bound
prior 28 33 1621 1626 I-upper_bound
to 34 36 1627 1629 O
baseline 37 45 1630 1638 O

Receipt 0 7 1639 1646 O
of 8 10 1647 1649 O
more 11 15 1650 1654 O
than 16 20 1655 1659 O
3 21 22 1660 1661 B-lower_bound
prior 23 28 1662 1667 B-treatment
regimens 29 37 1668 1676 I-treatment
of 38 40 1677 1679 I-treatment
cytotoxic 41 50 1680 1689 I-treatment
chemotherapy 51 63 1690 1702 I-treatment
for 64 67 1703 1706 O
metastatic 68 78 1707 1717 B-cancer
disease 79 86 1718 1725 I-cancer
unless 87 93 1726 1732 O
prior 94 99 1733 1738 O
approval 100 108 1739 1747 O
is 109 111 1748 1750 O
granted 112 119 1751 1758 O
by 120 122 1759 1761 O
the 123 126 1762 1765 O
Sponsor 127 134 1766 1773 O

Receipt 0 7 1774 1781 O
of 8 10 1782 1784 O
radiotherapy 11 23 1785 1797 B-treatment
to 24 26 1798 1800 O
> 27 28 1801 1802 O
25 28 30 1802 1804 B-lower_bound
% 31 32 1805 1806 I-lower_bound
of 33 35 1807 1809 O
bone 36 40 1810 1814 O
marrow 41 47 1815 1821 O

Serum 0 5 1822 1827 B-clinical_variable
albumin 6 13 1828 1835 I-clinical_variable
≥3.0 14 18 1836 1840 O
gm 19 21 1841 1843 I-lower_bound
/ 21 22 1843 1844 I-lower_bound
dL 22 24 1844 1846 I-lower_bound

Serum 0 5 1847 1852 B-clinical_variable
creatinine 6 16 1853 1863 I-clinical_variable
≤1.5 17 21 1864 1868 O
mg 22 24 1869 1871 I-upper_bound
/ 24 25 1871 1872 I-upper_bound
dL 25 27 1872 1874 I-upper_bound

Severe 0 6 1875 1881 O
liver 7 12 1882 1887 B-chronic_disease
dysfunction 13 24 1888 1899 I-chronic_disease
( 25 26 1900 1901 O
Child 26 31 1901 1906 O
- 31 32 1906 1907 O
Pugh 32 36 1907 1911 O
Class 37 42 1912 1917 O
B 43 44 1918 1919 O
or 45 47 1920 1922 O
C 48 49 1923 1924 O
) 49 50 1924 1925 O

Subjects 0 8 1926 1934 O
with 9 13 1935 1939 O
a 14 15 1940 1941 O
history 16 23 1942 1949 O
of 24 26 1950 1952 O
esophageal 27 37 1953 1963 O
bleeding 38 46 1964 1972 O
have 47 51 1973 1977 O
varices 52 59 1978 1985 O
that 60 64 1986 1990 O
have 65 69 1991 1995 O
been 70 74 1996 2000 O
sclerosed 75 84 2001 2010 O
or 85 87 2011 2013 O
banded 88 94 2014 2020 O
and 95 98 2021 2024 O
no 99 101 2025 2027 O
bleeding 102 110 2028 2036 O
episodes 111 119 2037 2045 O
have 120 124 2046 2050 O
occurred 125 133 2051 2059 O
during 134 140 2060 2066 O
the 141 144 2067 2070 O
prior 145 150 2071 2076 B-upper_bound
6 151 152 2077 2078 I-upper_bound
months 153 159 2079 2085 I-upper_bound

Subjects 0 8 2086 2094 O
with 9 13 2095 2099 O
primary 14 21 2100 2107 O
liver 22 27 2108 2113 B-cancer
cancer 28 34 2114 2120 I-cancer
or 35 37 2121 2123 O
hepatic 38 45 2124 2131 B-cancer
metastasis 46 56 2132 2142 I-cancer

Total 0 5 2143 2148 B-clinical_variable
bilirubin 6 15 2149 2158 I-clinical_variable
is 16 18 2159 2161 O
no 19 21 2162 2164 O
higher 22 28 2165 2171 O
than 29 33 2172 2176 O
the 34 37 2177 2180 O
ULN 38 41 2181 2184 O

Total 0 5 2185 2190 B-clinical_variable
bilirubin 6 15 2191 2200 I-clinical_variable
≤1.5 16 20 2201 2205 O
× 21 22 2206 2207 I-upper_bound
the 23 26 2208 2211 I-upper_bound
upper 27 32 2212 2217 I-upper_bound
limit 33 38 2218 2223 I-upper_bound
of 39 41 2224 2226 I-upper_bound
normal 42 48 2227 2233 I-upper_bound
( 49 50 2234 2235 I-upper_bound
ULN 50 53 2235 2238 I-upper_bound
) 53 54 2238 2239 I-upper_bound

Uncontrolled 0 12 2240 2252 O
congestive 13 23 2253 2263 B-chronic_disease
heart 24 29 2264 2269 I-chronic_disease
failure 30 37 2270 2277 I-chronic_disease
( 38 39 2278 2279 O
New 39 42 2279 2282 B-clinical_variable
York 43 47 2283 2287 I-clinical_variable
Heart 48 53 2288 2293 I-clinical_variable
Association 54 65 2294 2305 I-clinical_variable
Classification 66 80 2306 2320 I-clinical_variable
3 81 82 2321 2322 B-lower_bound
or 83 85 2323 2325 O
4 86 87 2326 2327 B-upper_bound
) 87 88 2327 2328 O
, 88 89 2328 2329 O
angina 90 96 2330 2336 O
, 96 97 2336 2337 O
myocardial 98 108 2338 2348 B-chronic_disease
infarction 109 119 2349 2359 I-chronic_disease
, 119 120 2359 2360 O
cerebrovascular 121 136 2361 2376 B-chronic_disease
accident 137 145 2377 2385 I-chronic_disease
, 145 146 2385 2386 O
coronary 147 155 2387 2395 B-treatment
/ 155 156 2395 2396 I-treatment
peripheral 156 166 2396 2406 I-treatment
artery 167 173 2407 2413 I-treatment
bypass 174 180 2414 2420 I-treatment
graft 181 186 2421 2426 I-treatment
surgery 187 194 2427 2434 I-treatment
, 194 195 2434 2435 O
transient 196 205 2436 2445 B-chronic_disease
ischemic 206 214 2446 2454 I-chronic_disease
attack 215 221 2455 2461 I-chronic_disease
, 221 222 2461 2462 O
or 223 225 2463 2465 O
pulmonary 226 235 2466 2475 B-chronic_disease
embolism 236 244 2476 2484 I-chronic_disease
within 245 251 2485 2491 O
3 252 253 2492 2493 B-upper_bound
months 254 260 2494 2500 I-upper_bound
prior 261 266 2501 2506 I-upper_bound
to 267 269 2507 2509 O
initiation 270 280 2510 2520 O
of 281 283 2521 2523 O
study 284 289 2524 2529 B-treatment
drug 290 294 2530 2534 I-treatment

Unstable 0 8 2535 2543 O
cardiac 9 16 2544 2551 B-chronic_disease
dysrhythmias 17 29 2552 2564 I-chronic_disease
or 30 32 2565 2567 O
persistent 33 43 2568 2578 O
prolongation 44 56 2579 2591 O
of 57 59 2592 2594 O
the 60 63 2595 2598 O
corrected 64 73 2599 2608 B-clinical_variable
QT 74 76 2609 2611 I-clinical_variable
interval 77 85 2612 2620 I-clinical_variable
( 86 87 2621 2622 I-clinical_variable
QTc 87 90 2622 2625 I-clinical_variable
) 90 91 2625 2626 I-clinical_variable
( 92 93 2627 2628 I-clinical_variable
Fridericia 93 103 2628 2638 I-clinical_variable
) 103 104 2638 2639 I-clinical_variable
to 105 107 2640 2642 O
> 108 109 2643 2644 O
450 109 112 2644 2647 B-lower_bound
msec 113 117 2648 2652 I-lower_bound
for 118 121 2653 2656 O
males 122 127 2657 2662 B-gender
or 128 130 2663 2665 O
> 131 132 2666 2667 O
470 132 135 2667 2670 B-lower_bound
msec 136 140 2671 2675 I-lower_bound
for 141 144 2676 2679 O
females 145 152 2680 2687 B-gender

corticosteroids 0 15 2688 2703 B-treatment
> 16 17 2704 2705 O
20 17 19 2705 2707 B-lower_bound
mg 20 22 2708 2710 I-lower_bound
/ 22 23 2710 2711 I-lower_bound
day 23 26 2711 2714 I-lower_bound
prednisone 27 37 2715 2725 B-treatment
or 38 40 2726 2728 O
equivalent 41 51 2729 2739 O
, 51 52 2739 2740 O
or 53 55 2741 2743 O
growth 56 62 2744 2750 B-treatment
factor 63 69 2751 2757 I-treatment
treatment 70 79 2758 2767 I-treatment
( 80 81 2768 2769 O
e.g. 81 85 2769 2773 O
, 85 86 2773 2774 O
erythropoietin 87 101 2775 2789 B-treatment
) 101 102 2789 2790 O
within 103 109 2791 2797 O
14 110 112 2798 2800 B-upper_bound
days 113 117 2801 2805 I-upper_bound
prior 118 123 2806 2811 I-upper_bound
to 124 126 2812 2814 O
initiation 127 137 2815 2825 O
of 138 140 2826 2828 O
study 141 146 2829 2834 B-treatment
drug 147 151 2835 2839 I-treatment

imaging 0 7 2840 2847 O
by 8 10 2848 2850 O
Response 11 19 2851 2859 O
Evaluation 20 30 2860 2870 O
Criteria 31 39 2871 2879 O
in 40 42 2880 2882 O
Solid 43 48 2883 2888 B-cancer
Tumors 49 55 2889 2895 I-cancer
( 56 57 2896 2897 O
RECIST 57 63 2897 2903 O
v1.1 64 68 2904 2908 O
, 68 69 2908 2909 O
Appendix 70 78 2910 2918 O
2 79 80 2919 2920 O
) 80 81 2920 2921 O

immunosuppressive 0 17 2922 2939 B-treatment
therapy 18 25 2940 2947 I-treatment

informative 0 11 2948 2959 O
tumor 12 17 2960 2965 B-cancer
marker(s 18 26 2966 2974 O
) 26 27 2974 2975 O

measured 0 8 2976 2984 B-clinical_variable
creatinine 9 19 2985 2995 I-clinical_variable
clearance 20 29 2996 3005 I-clinical_variable
≥60 30 33 3006 3009 O
mL 34 36 3010 3012 I-lower_bound
/ 36 37 3012 3013 I-lower_bound
min 37 40 3013 3016 I-lower_bound

non 0 3 3017 3020 B-cancer
- 3 4 3020 3021 I-cancer
squamous 4 12 3021 3029 I-cancer
- 12 13 3029 3030 I-cancer
cell 13 17 3030 3034 I-cancer
carcinoma 18 27 3035 3044 I-cancer
of 28 30 3045 3047 I-cancer
skin 31 35 3048 3052 I-cancer
or 36 38 3053 3055 O
carcinoma 39 48 3056 3065 B-cancer
in 49 51 3066 3068 I-cancer
- 51 52 3068 3069 I-cancer
situ 52 56 3069 3073 I-cancer
of 57 59 3074 3076 I-cancer
the 60 63 3077 3080 I-cancer
uterine 64 71 3081 3088 I-cancer
cervix 72 78 3089 3095 I-cancer
, 78 79 3095 3096 O
unless 80 86 3097 3103 O
the 87 90 3104 3107 O
tumor 91 96 3108 3113 B-cancer
was 97 100 3114 3117 O
treated 101 108 3118 3125 O
with 109 113 3126 3130 O
curative 114 122 3131 3139 B-treatment
intent 123 129 3140 3146 I-treatment
more 130 134 3147 3151 O
than 135 139 3152 3156 O
2 140 141 3157 3158 B-lower_bound
years 142 147 3159 3164 I-lower_bound
prior 148 153 3165 3170 I-lower_bound
to 154 156 3171 3173 O
study 157 162 3174 3179 O
entry 163 168 3180 3185 O

